Julien Miara is a Director at Invus. He joined in 2010 as an analyst in the Public Equity group, covering Biotechnology among other sectors.

In 2018, he was promoted to lead the team in Europe. Previously, he worked in investment banking at BNP Paribas in Paris and Société Générale in New-York, as well as in management consulting. Julien Miara received his Master of Management from EDHEC Business School in Lille (France) in 2009.

At its meeting on September 17, 2020, the Board of Directors of Onxeo co-opted Mr. Julien Miara, representing Invus Public Equities LP, as a director of the Company. This cooptation was ratified by the Company’s ordinary general meeting of June 10, 2021.

Mr. Julien Miara was appointed as interim CEO of Onxeo on January 3, 2022.